Le Lézard
Classified in: Health, Business
Subject: VEN

"Disrupt" introduces Disrupt Health Impact Fund with leading business groups in Thailand to invest in HealthTech startups globally


BANGKOK, May 30, 2024 /PRNewswire/ -- Disrupt Technology Venture ("Disrupt") announced the introduction of Disrupt Health Impact Fund with the first group of co-investment partners from leading Thai business companies ? Digital Health Ventures ("DHV"), the innovation and venture arm of Samitivej Hospital Group, Thana Asset Company Limited ("THANA"), Saha Pathana Inter-Holding Public Company Limited ("SPI") and Sripatum University ("SPU"). Disrupt Health Impact Fund is dedicated in providing Thailand's healthcare sector with access to world-class deep technology (DeepTech) and improving healthcare services for the Thai people. Managed by an experienced team that oversees over 6 funds which have invested in 134 companies across 16 countries, the fund plans to invest in DeepTech companies in the healthcare field, both domestically and internationally. This initiative aims to enhance the healthcare ecosystem, giving Thai people access to world-class health technologies.

Mr. Krating Poonpol, Chairman of Disrupt Health Impact Fund revealed "The healthcare market, valued at over US$9 trillion or more than 330 trillion Thai baht, represents a trillion-dollar industry and a mega trend that will gain even greater importance in the future."

Ms. Jantanarak Tuekaew, Partner of Disrupt Health Impact Fund added that, "Thailand has been ranked among the top ten in terms of health security and medical tourism. This presents an opportune moment for both Thai and foreign entrepreneurs. Disrupt Health Impact Fund is committed to investing in five key areas: Self Care, Preventive Care, Silver Age, Holistic Wellness, and Smart Hospital. The fund also aims to be the gateway to Southeast Asia for DeepTech companies in the healthcare sector by leveraging healthcare expertise from both public and private sectors."

Mr. Pithon Vithayasricharoen, Managing Director of Digital Health Ventures ("DHV"), the innovation and venture arm of Samitivej Hospital Group, said "Our experience in healthcare services has highlighted opportunities in early care and risk care. We believe that technology is the key to keeping people healthy and reducing dependence on medical professionals. Disrupt Health Impact Fund's mission aligns with DHV to benefit society by merging our partners' expertise to positively impact the country."

Disrupt Health Impact Fund is managed by an experienced team led by Mr. Krating Poonpol, Ms. Jantanarak Tuekaew and Ms. Naranpat Thitipattakul. Collectively, they have overseen 6 Accelerator and VC funds, including 500 TukTuks, ORZON Ventures, Stormbreaker Ventures, and KXVC.

For more information about Disrupt Health Impact Fund: https://www.disruptignite.com/impactfund

Photos:
https://drive.google.com/drive/folders/1aygw0WU2sR5vpdmrXTMj96hiW8ZCBFYX

SOURCE Disrupt Technology Venture


These press releases may also interest you

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...



News published on and distributed by: